The Cigna Group (NYSE:CI) Shares Acquired by Turtle Creek Wealth Advisors LLC

Turtle Creek Wealth Advisors LLC lifted its holdings in shares of The Cigna Group (NYSE:CI) by 3.5% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,261 shares of the health services provider’s stock after purchasing an additional 510 shares during the quarter. Turtle Creek Wealth Advisors LLC’s holdings in The Cigna Group were worth $5,287,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in CI. Avantax Advisory Services Inc. boosted its holdings in The Cigna Group by 8.5% in the first quarter. Avantax Advisory Services Inc. now owns 3,612 shares of the health services provider’s stock valued at $1,312,000 after acquiring an additional 284 shares during the last quarter. Lord Abbett & CO. LLC boosted its holdings in The Cigna Group by 43.9% in the first quarter. Lord Abbett & CO. LLC now owns 3,969 shares of the health services provider’s stock valued at $1,441,000 after acquiring an additional 1,211 shares during the last quarter. Banco Santander S.A. boosted its holdings in The Cigna Group by 379.4% in the first quarter. Banco Santander S.A. now owns 7,153 shares of the health services provider’s stock valued at $2,598,000 after acquiring an additional 5,661 shares during the last quarter. M&G Plc acquired a new position in The Cigna Group in the first quarter valued at $8,648,000. Finally, Mizuho Markets Americas LLC acquired a new position in The Cigna Group in the first quarter valued at $4,389,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Stock Down 0.7 %

The Cigna Group stock traded down $2.36 during midday trading on Friday, hitting $321.52. The stock had a trading volume of 1,650,180 shares, compared to its average volume of 1,545,534. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The stock has a market cap of $89.43 billion, a P/E ratio of 30.33, a P/E/G ratio of 1.00 and a beta of 0.51. The Cigna Group has a 12 month low of $253.95 and a 12 month high of $370.83. The business has a fifty day moving average price of $338.88 and a 200 day moving average price of $339.67.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating the consensus estimate of $7.22 by $0.29. The firm had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The Cigna Group’s quarterly revenue was up 29.8% on a year-over-year basis. During the same period in the previous year, the company earned $6.77 earnings per share. Research analysts predict that The Cigna Group will post 28.5 EPS for the current year.

The Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be issued a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.74%. The ex-dividend date is Wednesday, December 4th. The Cigna Group’s dividend payout ratio is currently 52.83%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on CI shares. Deutsche Bank Aktiengesellschaft reduced their target price on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Royal Bank of Canada reduced their price objective on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Stephens restated an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a research note on Friday, November 1st. Jefferies Financial Group boosted their price objective on The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a research note on Tuesday, September 17th. Finally, Barclays boosted their price objective on The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $394.64.

Insider Activity

In other news, Director William J. Delaney III sold 2,691 shares of the stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the sale, the director now directly owns 17,539 shares in the company, valued at approximately $6,010,264.52. This represents a 13.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.60% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.